Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Modern Health Portugal.
Portugal Surpasses UK and US in Global Passport Ranking
Portugal outranks US and UK in new passport index, with tax benefits, EU access and lifestyle driving its rise to fourth place globally. LISBON, PORTUGAL, September 18, 2025 /EINPresswire.com/ -- Portugal has been ranked the world’s fourth most...
AIDA Country Report on Portugal – Update on 2024
|Published on: 11th September 2025|Categories: News| The updated AIDA Country Report on Portugal provides a detailed overview on legislative and practice-related developments in asylum procedures, reception conditions, detention of asylum...
Owner: ECRE (Non-profit)
Medāna Brings Its Risk-Based AI Platform to Poland, Advancing Patient-Centered Healthcare Across Europe
LISBON, Portugal, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Poland is about to welcome one of the most disruptive innovations in digital health. Medāna (www.medana.ai), the global company founded by Dr. Tal Patalon, today announced its strategic entry...
Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025
Results presented focus on clinical insights on Fabry disease and alpha-mannosidosis Additional presentations showcase patient-reported journeys and outcomes PARMA, Italy, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business...
Chinese President Holds Meeting with Portuguese PM
(MENAFN) Chinese President Xi Jinping held a meeting with Portuguese Prime Minister Luis Montenegro in Beijing on Tuesday, emphasizing the strong and growing relationship between the two nations. During the meeting, Xi highlighted the significant...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Questex’s StreamTV Europe Opens Call for Speakers for Inaugural Event in Lisbon, Portugal
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- StreamTV Europe, the premier European edition of Questex’s acclaimed StreamTV Show, today opens the call for speakers for the inaugural event. StreamTV Europe will convene the top minds in streaming,...
GlobalEdgeMarkets Partners with Business Finland to Launch the ‘Find Your Superposition in Finland’ Campaign
Collaboration to attract Deep Tech and Health Tech experts to Finland through the “Find Your Superposition in Finland” campaign. NEW YORK, NY, UNITED STATES, September 17, 2025 /EINPresswire.com/ -- GlobalEdgeMarkets Partners with Business...
United Planet Elects Four New Board Members to Advance Global Service and Cross-Cultural Understanding
United Planet welcomes Jakob Rusinek, João Chagas, Nadjmat Abdoulhakime, and Poncelet Ileleji to its board to strengthen its mission worldwide. BOSTON, MA, UNITED STATES, September 18, 2025 /EINPresswire.com/ -- United Planet, a leading...
Starwood Pet Travel Sets New Standard for International Pet Relocation in 2025
Cape Coral, FLORIDA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Starwood Pet Travel, a global leader in pet relocation, has been featured in USA Today for redefining what it means to move pets across international borders. The article, titled “Navigating...
Olive Oil Market Size to Worth USD 30,631.81 Million by 2032 | CAGR of 6.04% during 2025-2032
The olive oil market report covers key companies, including Deoleo S.A. (Spain), Sovena Group (Portugal), Del Monte Foods, Inc. (U.S.), & Others. NY, UNITED STATES, September 17, 2025 /EINPresswire.com/ -- Report Overview: The global olive oil...
Biogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome
– Durable reductions in seizures and continuing improvements in cognition and behavior through 3 years in patients who continued to receive zorevunersen in the open-label extension studies – – Substantial increase in seizure-free days and...
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or Very High-Risk Patients Based on REDUCE-IT -- DUBLIN and BRIDGEWATER, N.J., Aug. 30, 2025 (GLOBE NEWSWIRE)...
Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains
LONDON and NEUMÜNSTER, Germany, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between...
NEW: Food Allergy Emergency Care Plan Empowers Self-Care and Reduces Health Care Costs
Washington, DC, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) announces the availability of the first validated food allergy anaphylaxis action plan, including versions for children under age 3 and children...
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, today announced its participation in...
Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
– 3-year data from open-label extension (OLE) studies demonstrate the potential for disease modification with durable seizure reductions and improvements in cognition and behavior on top of standard anti-seizure medicines – – Substantial...
PannTheraPi prepares plans to conduct its first Phase IIa clinical trial with PTI5803 in patients with resistant epilepsy and accelerate the development of its proprietary pipeline
PannTheraPi prepares plans to conduct its first Phase IIa clinical trial with PTI5803 in patients with resistant epilepsy and accelerate the development of its proprietary pipeline Pre-submission file completed with French regulatory agency (ANSM)...
“Art Exhibition for All” of the 23rd Macao City Fringe Festival inaugurated presenting a range of programmes in various districts
MACAU, September 16 - Organised by the Cultural Affairs Bureau (IC, from the Portuguese acronym), the “Art Exhibition for All”, integrated in the 23rd Macao City Fringe Festival, was inaugurated today (16 September) at the Flower City Park in...
Owner: Macau Government
NVIDIA and United Kingdom Build Nation’s AI Infrastructure and Ecosystem to Fuel Innovation, Economic Growth and Jobs
News Summary: NVIDIA partners with Nscale, the U.K. AI infrastructure company, to scale up 300,000 NVIDIA Grace Blackwell GPUs worldwide, with up to 60,000 GPUs in the U.K. NVIDIA and AI infrastructure partners Nscale, CoreWeave and others to...